Alpha Teknova, Inc. (TKNO)
USD 6.54
(1.71%)
USD 6.54
(1.71%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 128.58 Million USD | -15.55% |
| 2022 | 152.26 Million USD | -8.56% |
| 2021 | 166.51 Million USD | 164.68% |
| 2020 | 62.91 Million USD | 7.52% |
| 2019 | 58.51 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 115.35 Million USD | -4.52% |
| 2024 Q1 | 120.81 Million USD | -6.04% |
| 2023 Q1 | 141.02 Million USD | -7.38% |
| 2023 Q3 | 138.38 Million USD | 4.4% |
| 2023 FY | 128.58 Million USD | -15.55% |
| 2023 Q2 | 132.54 Million USD | -6.01% |
| 2023 Q4 | 128.58 Million USD | -7.08% |
| 2022 Q3 | 160.27 Million USD | -12.03% |
| 2022 FY | 152.26 Million USD | -8.56% |
| 2022 Q4 | 152.26 Million USD | -5.0% |
| 2022 Q2 | 182.19 Million USD | -1.03% |
| 2022 Q1 | 184.08 Million USD | 10.55% |
| 2021 FY | 166.51 Million USD | 164.68% |
| 2021 Q3 | 169.16 Million USD | -1.97% |
| 2021 Q2 | 172.56 Million USD | 126.7% |
| 2021 Q1 | 76.12 Million USD | 21.0% |
| 2021 Q4 | 166.51 Million USD | -1.57% |
| 2020 Q4 | 62.91 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 62.91 Million USD | 7.52% |
| 2019 FY | 58.51 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 82.344% |
| PainReform Ltd. | 9.93 Million USD | -1194.935% |
| Alvotech | 950.09 Million USD | 86.466% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 88.753% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 85.782% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | -123.949% |
| Journey Medical Corporation | 76.84 Million USD | -67.324% |
| Dynavax Technologies Corporation | 997.09 Million USD | 87.104% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | 37.517% |
| Bright Green Corporation | 17.4 Million USD | -638.876% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 91.833% |
| Embecta Corp. | 1.21 Billion USD | 89.411% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -370.206% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -370.206% |
| SCYNEXIS, Inc. | 128.41 Million USD | -0.136% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -280.482% |
| Silver Spike Investment Corp. | 88.57 Million USD | -45.171% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -456.002% |
| Safety Shot Inc | 12.7 Million USD | -911.765% |
| Procaps Group, S.A. | 460.18 Million USD | 72.058% |
| Cosmos Health Inc. | 66.29 Million USD | -93.96% |
| Theratechnologies Inc. | 77.76 Million USD | -65.345% |
| Harrow Health, Inc. | 311.75 Million USD | 58.754% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -763.406% |
| Biofrontera Inc. | 27.93 Million USD | -360.357% |
| DURECT Corporation | 45.18 Million USD | -184.554% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 90.874% |
| Cronos Group Inc. | 1.13 Billion USD | 88.663% |
| OptiNose, Inc. | 107.72 Million USD | -19.362% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 72.703% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -129.829% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -457.93% |
| Organogenesis Holdings Inc. | 460.02 Million USD | 72.048% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -978.915% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -57.243% |
| Radius Health, Inc. | 1.71 Billion USD | 92.506% |
| Universe Pharmaceuticals INC | 53.28 Million USD | -141.31% |
| ProPhase Labs, Inc. | 91.92 Million USD | -39.879% |
| Phibro Animal Health Corporation | 982.18 Million USD | 86.908% |
| Procaps Group S.A. | 460.18 Million USD | 72.058% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -196.906% |
| Viatris Inc. | 47.68 Billion USD | 99.73% |
| Rockwell Medical, Inc. | 52.17 Million USD | -146.463% |
| Aytu BioPharma, Inc. | 118.09 Million USD | -8.884% |
| SIGA Technologies, Inc. | 254.83 Million USD | 49.541% |
| Tilray Brands, Inc. | 4.33 Billion USD | 97.034% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | 53.019% |
| Shineco, Inc. | 84.17 Million USD | -52.754% |
| PetIQ, Inc. | 868.22 Million USD | 85.19% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -1423.866% |
| Incannex Healthcare Limited | 17.04 Million USD | -654.309% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 96.045% |
| Alimera Sciences, Inc. | 153.52 Million USD | 16.243% |
| Assertio Holdings, Inc. | 286.41 Million USD | 55.105% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -2060.496% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -311.571% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -870.648% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | 50.757% |
| Hempacco Co., Inc. | 18.04 Million USD | -612.667% |
| Talphera, Inc. | 20.39 Million USD | -530.483% |
| Alvotech | 950.09 Million USD | 86.466% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 68.341% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 92.212% |
| Currenc Group, Inc. | 141.49 Million USD | 9.12% |
| Kamada Ltd. | 351.96 Million USD | 63.466% |
| Indivior PLC | 1.95 Billion USD | 93.41% |
| Evoke Pharma, Inc. | 7.06 Million USD | -1719.144% |
| Flora Growth Corp. | 23.62 Million USD | -444.261% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -870.648% |
| Evolus, Inc. | 188.99 Million USD | 31.964% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 89.952% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 91.501% |
| Akanda Corp. | 8.83 Million USD | -1354.605% |